Surrozen (SRZN) Shares Outstanding (Weighted Average) (2020 - 2026)

Surrozen (SRZN) recorded quarterly Shares Outstanding (Weighted Average) of $10949.0 in Q1 2026, down 99.91% quarter-over-quarter from $12.7 million in Q4 2025, and down 99.92% on a YoY basis from $13.0 million in Q1 2025.

Surrozen (SRZN) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Surrozen's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $10949.0 for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 99.92% year-over-year to $10949.0; the TTM figure through Mar 2026 stood at $10949.0 (down 99.92% YoY), while the FY2025 annual figure was $12.7 million, up 432903.75% from the prior year.
  • Shares Outstanding (Weighted Average) was $10949.0 for Q1 2026 at Surrozen, down from $12.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $34.9 million in Q2 2022 to a low of $1998.0 in Q1 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $8.4 million across 5 years, with a median of $2.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) slumped 99.99% in 2023, then jumped 492234.1% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2314.0 in 2022, then retreated by 12.79% to $2018.0 in 2023, then jumped by 45.34% to $2933.0 in 2024, then soared by 432903.75% to $12.7 million in 2025, then sank by 99.91% to $10949.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $10949.0 (Q1 2026), $12.7 million (Q4 2025), and $8571.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 185,491.37 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 400.00 Bn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 417.01 Bn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 254.10 Mn
9 Abivax 94.37 Bn 94.37 Bn - 928.40 Mn
10 Surrozen 225,877.86 -106.68 Mn - 10,949.00

Historic Data

Download Data
DateValue
Mar 31, 2026 10,949.00
Dec 31, 2025 12.70 Mn
Sep 30, 2025 8,571.00
Jun 30, 2025 12.91 Mn
Mar 31, 2025 12.98 Mn
Dec 31, 2024 2,933.00
Sep 30, 2024 17.08 Mn
Jun 30, 2024 2,622.00
Mar 31, 2024 5.91 Mn
Dec 31, 2023 2,018.00
Sep 30, 2023 2.03 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 1,998.00
Dec 31, 2022 2,314.00
Sep 30, 2022 7.22 Mn
Jun 30, 2022 34.95 Mn
Mar 31, 2022 34.86 Mn
Dec 31, 2021 24,689.00
Sep 30, 2021 7.22 Mn
Jun 30, 2021 8.16 Mn